title: Endogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasis.
abstract: Disseminated Candida albicans infection results in high morbidity and mortality despite treatment with existing antifungal drugs. Recent studies suggest that modulating the host immune response can improve survival, but specific host targets for accomplishing this goal remain to be identified. The extracellular matrix protein thrombospondin-1 is released at sites of tissue injury and modulates several immune functions, but its role in C. albicans pathogenesis has not been investigated. Here, we show that mice lacking thrombospondin-1 have an advantage in surviving disseminated candidiasis and more efficiently clear the initial colonization from kidneys despite exhibiting fewer infiltrating leukocytes. By examining local and systemic cytokine responses to C. albicans and other standard inflammatory stimuli, we identify a crucial function of phagocytes in this enhanced resistance. Subcutaneous air pouch and systemic candidiasis models demonstrated that endogenous thrombospondin-1 enhances the early innate immune response against C. albicans and promotes activation of inflammatory macrophages (inducible nitric oxide synthase⁺, IL-6(high), TNF-α(high), IL-10(low)), release of the chemokines MIP-2, JE, MIP-1α, and RANTES, and CXCR2-driven polymorphonuclear leukocytes recruitment. However, thrombospondin-1 inhibited the phagocytic capacity of inflammatory leukocytes in vivo and in vitro, resulting in increased fungal burden in the kidney and increased mortality in wild type mice. Thus, thrombospondin-1 enhances the pathogenesis of disseminated candidiasis by creating an imbalance in the host immune response that ultimately leads to reduced phagocytic function, impaired fungal clearance, and increased mortality. Conversely, inhibitors of thrombospondin-1 may be useful drugs to improve patient recovery from disseminated candidiasis.
authors.affiliation: Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
authors.forename: Gema
authors.initials: G
authors.lastname: Martin-Manso
authors.forename: Dhammika H M L P
authors.initials: DH
authors.lastname: Navarathna
authors.forename: Susana
authors.initials: S
authors.lastname: Galli
authors.forename: David R
authors.initials: DR
authors.lastname: Soto-Pantoja
authors.forename: Svetlana A
authors.initials: SA
authors.lastname: Kuznetsova
authors.forename: Maria
authors.initials: M
authors.lastname: Tsokos
authors.forename: David D
authors.initials: DD
authors.lastname: Roberts
mesh_terms: D000818:Animals; D002176:Candida albicans / Q000276:immunology; D002177:Candidiasis / Q000276:immunology* / Q000401:mortality; D016207:Cytokines / Q000276:immunology; D004198:Disease Susceptibility / Q000276:immunology; D006801:Humans; D056724:Immunity, Humoral / Q000502:physiology; D007668:Kidney / Q000276:immunology / Q000382:microbiology; D051379:Mice; D008810:Mice, Inbred C57BL; D018448:Models, Immunological; D009504:Neutrophils / Q000276:immunology* / Q000502:physiology; D009573:Nitrites / Q000378:metabolism; D010586:Phagocytes / Q000276:immunology* / Q000502:physiology; D019700:Thrombospondin 1 / Q000235:genetics / Q000276:immunology* / Q000502:physiology; D020298:U937 Cells
chemical_list: D016207:Cytokines; D009573:Nitrites; D019700:Thrombospondin 1